a public good project by the
Synthesis
Company
of California

© 2026

Karl H. Weisgraber | doi.page

0 works0 citations0 h-index

Karl H. Weisgraber

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Alzheimer's disease research and treatments, Cancer, Lipids, and Metabolism, Peroxisome Proliferator-Activated Receptors

Most-Cited Works

→ Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.(1993)1,360 cited
→ Plasma lipoproteins: apolipoprotein structure and function.(1984)1,154 cited
→ Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease(2006)910 cited
→ Apolipoprotein E: Structure-Function Relationships(1994)817 cited
→ Differential Effects of Apolipoproteins E3 and E4 on Neuronal Growth in Vitro(1994)799 cited
→ Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.(1981)773 cited

→ Human apolipoprotein E. The complete amino acid sequence.(1982)

737 cited

→ Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.(1987)706 cited

→ Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.(1982)674 cited

→ Three-Dimensional Structure of the LDL Receptor-Binding Domain of Human Apolipoprotein E(1991)669 cited